Humoral immunity in chronic allograft rejection: puzzle pieces come together (Q33352583)

26 July 2017

Humoral immunity in chronic allograft rejection: puzzle pieces come together (English)

1 reference

26 July 2017

Olivier Thaunat

1

1 reference

26 July 2017

12 November 2011

1 reference

26 July 2017

Transplant Immunology

1 reference

26 July 2017

26

1 reference

26 July 2017

2-3

1 reference

26 July 2017

101-106

1 reference

Long-term renal allograft survival in the United States: a critical reappraisal

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Humoral Antibodies in Renal Allotransplantation in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Immunologic basis of transplant-associated arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Two levels of help for B cell alloantibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Characterization, evolution, and molecular basis of a polymorphic antigenic determinant shared by HLA-A and B products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Non-MHC antigenic targets of the humoral immune response in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

The impact of glycosylation on the biological function and structure of human immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Capillary deposition of C4d complement fragment and early renal graft loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Involvement of antibody-dependent apoptosis in graft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Open conformers: the hidden face of MHC-I molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Transplantation of discordant xenografts: a review of progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Heme oxygenase: protective gene or Trojan horse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Accommodation of grafts: implications for health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Superantibody activities: new players in innate and adaptive immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

B cells acquire antigen from target cells after synapse formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

The B-cell response to protein antigens in immunity and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

A critical role for B cells in the development of memory CD4 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Characterization of intra-graft B cells during renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Lymphoid neogenesis in chronic rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Pathophysiologic significance of B-cell clusters in chronically rejected grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Is defective lymphatic drainage a trigger for lymphoid neogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Immune responses elicited in tertiary lymphoid tissues display distinctive features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Feedback suppression of the immune response in vivo. I. Immune B cells induce antigen-specific suppressor T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

B cells regulate autoimmunity by provision of IL-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Prevention of arthritis by interleukin 10-producing B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

B-cell-depleting induction therapy and acute cellular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Identification of a B cell signature associated with renal transplant tolerance in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.11.003

10.1016/J.TRIM.2011.11.003

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

22108536